» Articles » PMID: 27780863

Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2016 Oct 27
PMID 27780863
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Protein 4.1R (4.1R) isoforms are expressed in both cardiac and skeletal muscle. 4.1R is a component of the contractile apparatus. It is also associated with dystrophin at the sarcolemma in skeletal myofibers. However, the expression and function of 4.1R during myogenesis have not been characterized. We now report that 4.1R expression increases during C2C12 myoblast differentiation into myotubes. Depletion of 4.1R impairs skeletal muscle differentiation and is accompanied by a decrease in the levels of myosin heavy and light chains and caveolin-3. Furthermore, the expression of myogenin at the protein, but not mRNA, level is drastically decreased in 4.1R knockdown myocytes. Similar results were obtained using MyoD-induced differentiation of 4.1R mouse embryonic fibroblast cells. von Hippel-Lindau (VHL) protein is known to destabilize myogenin via the ubiquitin-proteasome pathway. We show that 4.1R associates with VHL and, when overexpressed, reverses myogenin ubiquitination and stability. This suggests that 4.1R may influence myogenesis by preventing VHL-mediated myogenin degradation. Together, our results define a novel biological function for 4.1R in muscle differentiation and provide a molecular mechanism by which 4.1R promotes myogenic differentiation.

Citing Articles

Differential analysis of ubiquitin-proteomics in skeletal muscle of Duroc pigs and Tibetan fragrant pigs.

Li M, Li C, Chen X, Yao Y, Han Y, Guo T Front Vet Sci. 2024; 11:1455338.

PMID: 39280835 PMC: 11395495. DOI: 10.3389/fvets.2024.1455338.


Cytoskeletal Protein 4.1R in Health and Diseases.

Liu J, Ding C, Liu X, Kang Q Biomolecules. 2024; 14(2).

PMID: 38397451 PMC: 10887211. DOI: 10.3390/biom14020214.


Role of Actin-Binding Proteins in Skeletal Myogenesis.

Nguyen M, Dash R, Jeong K, Lee W Cells. 2023; 12(21).

PMID: 37947600 PMC: 10650911. DOI: 10.3390/cells12212523.


High-intensity circuit training change serum myostatin but not myogenin in adolescents' soccer players: a quasi-experimental study.

Ziyaiyan A, Kordi M, Hofmeister M, Chamari K, Moalla W, Gaeini A BMC Sports Sci Med Rehabil. 2023; 15(1):15.

PMID: 36747295 PMC: 9901002. DOI: 10.1186/s13102-023-00627-1.


The Gentle Side of the UPS: Ubiquitin-Proteasome System and the Regulation of the Myogenic Program.

Olguin H Front Cell Dev Biol. 2022; 9:821839.

PMID: 35127730 PMC: 8811165. DOI: 10.3389/fcell.2021.821839.


References
1.
Taylor-Harris P, Keating L, Maggs A, Phillips G, Birks E, Franklin R . Cardiac muscle cell cytoskeletal protein 4.1: analysis of transcripts and subcellular location--relevance to membrane integrity, microstructure, and possible role in heart failure. Mamm Genome. 2005; 16(3):137-51. DOI: 10.1007/s00335-004-2436-7. View

2.
Krauss S, Chen C, Penman S, Heald R . Nuclear actin and protein 4.1: essential interactions during nuclear assembly in vitro. Proc Natl Acad Sci U S A. 2003; 100(19):10752-7. PMC: 196875. DOI: 10.1073/pnas.1934680100. View

3.
Yu Y, Khan J, Khanna C, Helman L, Meltzer P, Merlino G . Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004; 10(2):175-81. DOI: 10.1038/nm966. View

4.
Yamaguchi A . Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily. Semin Cell Biol. 1995; 6(3):165-73. DOI: 10.1006/scel.1995.0023. View

5.
Banks G, Chamberlain J . The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. Curr Top Dev Biol. 2009; 84:431-53. DOI: 10.1016/S0070-2153(08)00609-1. View